씨티씨바이오

060590KOSDAQ

56.8 / 100

Reference Date: 2026-09-08

Financial Score19.5 / 40

News Sentiment21.3 / 25

Momentum6.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Slightly up 2.1% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

CTC Bio operates in the animal and human pharmaceutical sectors, leveraging core technologies such as microbial fermentation, drug coating, and DDS to develop diverse products. Its key revenue drivers include award-winning products like CTCZYME and ODF films, while the company actively manages foreign exchange risks to strengthen its global competitiveness.

Number of Employees

237people

Average Salary

46.8M KRW

Score Calculation Basis

Detailed Financial Score

PER

22.85Industry Average 15.001.5Point

1.5x industry avg (risky)

PBR

1.04Industry Average 1.204.0Point

In line with industry avg

ROE

4.55Industry Average 8.002.5Point

Below industry avg

Debt Ratio

27.63Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20253.5 / 10 points

Revenue Growth Rate

0.5 / 3

Avg ▼4.8% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲135.9% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -7.0% (improving, 3yr)

Detailed News Sentiment

2 totalPositive 2Neutral 0Negative 0Average Sentiment Score 85

Positive
씨티씨바이오 "브라질서 베타-만난아제·박테리오파지 기술 주목 ... 중...
씨티씨바이오의 중남미 시장 진출 기반 확보로 인해 긍정적인 미래 전망이 제시되었다.
Positive
씨티씨바이오, 상반기 영업익 272%↑…전 사업부문 흑자
씨티씨바이오의 상반기 영업이익이 전년 동기 대비 272% 증가하며 전 사업부문의 흑자 달성으로 긍정적인 실적을 보였다.

Detailed Momentum

52-week position1.0Point

Near 52w low (9%, downtrend)

Current 3,130Won52-week high 7,45052-week low 2,700

1-month return4.0Point

1m +2.12% (slight rise)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral반기보고서 (2026.06)2026-08-12